dimanche, 22 juillet 2018 - 23:33
  • it
  • de
  • en
  • fr

Sangamo Therapeutics

Pfizer signs $160m cooperation agreement with Sangamo Therapeutics

Pfizer and Sangamo Therapeutics have announced a cooperation aimed at using the “zinc finger therapy” for the treatment of ALS linked to mutations of the C9ORF72 gene. Thanks to the agreement, Sangamo will receive $12m from Pfizer, plus a potential…